Doebele Robert 4
4 · Rain Therapeutics Inc. · Filed Jul 7, 2022
Insider Transaction Report
Form 4
Doebele Robert
EVP, Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-07-06$3.95/sh+3,890$15,366→ 476,827 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-07-06−3,890→ 5,000 totalExercise: $3.95Exp: 2029-03-13→ Common Stock (3,890 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 13,890 shares of Issuer's common stock, which is vested in full.